Agranulocytosis Induced by Trimeprazine
- 19 February 1959
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 260 (8) , 378-380
- https://doi.org/10.1056/nejm195902192600807
Abstract
PHENOTHIAZINE derivatives have long been known to have serious toxic effects in a small number of susceptible persons. Among these reactions are hepatic damage, epileptic seizures, Parkinson's disease, various skin disorders and hematopoietic depression.1 2 3 4 5 6 7 8 9 10 It is the purpose of this report to call attention to the hematotoxic potentialities of a new member of this pharmacologic family, trimeprazine. The drug has been under clinical trial for nearly two years and has recently been released to the medical profession. It shares a number of the useful properties of the phenothiazine drugs, and has been found to be particularly effective as an antipruritic . . .Keywords
This publication has 10 references indexed in Scilit:
- Agranulocytosis after Promazine TherapyNew England Journal of Medicine, 1957
- CASE REPORTSAmerican Journal of Psychiatry, 1957
- CLINICAL NOTESAmerican Journal of Psychiatry, 1956
- FATAL AGRANULOCYTOSIS OCCURRING DURING PROMAZINE (SPARINE) THERAPYJAMA, 1956
- AGRANULOCYTOSIS DURING TREATMENT WITH PACATALThe Lancet, 1956
- Agranulocytosis Associated with Chlorpromazine TherapyNew England Journal of Medicine, 1956
- Agranulocytosis Associated with Chlorpromazine TherapyArchives of internal medicine (1960), 1955
- COMPLICATIONS OF CHLORPROMAZINE THERAPY IN 800 MENTAL-HOSPITAL PATIENTSThe Lancet, 1955
- AGRANULOCYTOSIS FOLLOWING USE OF CHLORPROMAZINE THERAPYJAMA, 1955
- AGRANULOCYTOSIS ASSOCIATED WITH ADMINISTRATION OF THORAZINEJAMA, 1955